Graphpad Software, LLC
Boston, MA
- UEI
- NH43R2NEKRC8
- CAGE
- 1GVL3
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Pasadena, CA RNPFT3AY4795
- Boston, MA H7DLYGSEN1A5
- M78LBLFHT5S4
- Boston, MA QJT4CCNQK6M9
- Boston, MA FMJKSBHESYC7
- Boston, MA E1WQL3WDJHR5
- Boston, MA D3ZDKNNU9PT9
- Softgenetics, LLC · State College, PA QLP9HB3G3UY5
- Boston, MA TSLZN8ZZNMH8
-
- SAM.gov registration date
- Physical address
- 225 Franklin St, Boston, MA 02110, USA
- Website
- graphpad.com
- Founded
- 1989
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Information Technology
- Software & Services
- Internet Software & Services
- SIC code
- 73 Business Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $208,347 |
| FY2025 | $322,295 |
| FY2024 | $189,679 |
| FY2023 | $210,548 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $114,957 | |
| 2 | Defense Health Agency | $76,000 | |
| 3 | Environmental Protection Agency | $17,390 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Genedata (Usa), Inc. | Lexington, MA | 513210 Software Publishers |
| Biomatters LIMITED | — | — |
| Virscidian LLC | Boston, MA | 541511 Custom Computer Programming Services |
| Gene Codes Corp | Ann Arbor, MI | 513210 Software Publishers |
| Sentieon Inc. | San Jose, CA | 513210 Software Publishers |
About the company
Graphpad Software, LLC, a foreign-owned for-profit software company headquartered in Boston, Massachusetts, supplies scientific data analysis, statistical graphing, and sequence analysis software exclusively as a prime contractor to federal research agencies on firm-fixed-price purchase orders, with no set-aside designations across a 184-award footprint spanning twenty years.
Graphpad's federal portfolio centers on two flagship products: Prism, a statistical analysis and visualization platform, and Geneious, a sequence analysis and data management tool. The company competes in full-and-open procurements, predominantly under NAICS 541512 (Computer Systems Design Services) and PSC codes for information technology and laboratory software. Recent representative awards include a $51 thousand purchase order from the National Institute of Child Health and Human Development for Prism software (September 2026), a $76 thousand Defense Health Agency license for Graphpad software (June 2026), a $39 thousand NIH Clinical Center procurement for data analysis software (March 2026), and a $36.8 thousand Department of Agriculture Plant Protection and Quarantine renewal of nineteen Geneious licenses supporting veterinary biologics testing (August 2025). The vendor's award history reflects continuous federal customer relationships dating to 2006, with individual contract values typically ranging from $11 thousand to $65 thousand per annual subscription renewal.
Customer concentration is distributed across federal research institutions. The top five customer agencies, covering 44 percent of combined potential value, are the National Institute of Diabetes and Digestive and Kidney Diseases (13 awards, $361 thousand), the Army Medical Command (9 awards, $307 thousand), the National Institute of Environmental Health Sciences (10 awards, $270 thousand), the Defense Health Agency (5 awards, $230 thousand), and the National Institute of Child Health and Human Development (11 awards, $187 thousand). The National Institutes of Health and subordinate institutes dominate Graphpad's portfolio by both award count and dollar value; combined NIH component awards represent the vast majority of the $3.1 million in recent obligated value across all 184 awards. Activity has remained flat to slight decline over the past five years—nine awards in 2022, ten in 2023 and 2024, eleven in 2025, and three to date in 2026. Five awards carrying combined potential value of $208 thousand reach ultimate completion within the next twenty-four months and face recompete exposure.
Graphpad operates as a parent entity overseeing nine named subsidiaries: Softgenetics LLC, Omiq LLC, Virscidian LLC, Protein Metrics LLC, Labarchives LLC, Dotmatics LLC, GSL Biotech LLC (self-certified small disadvantaged business), De Novo Software LLC (foreign-owned, self-certified small disadvantaged business), and M-Star Simulations LLC. These subsidiaries extend the parent's software and analytical-services portfolio across genomics, laboratory informatics, chemistry, and computational chemistry domains, though the parent company remains the federal contracting prime. Graphpad maintains no federal subcontract footprint and no participation on government-wide vehicles, IDIQs, BPAs, or GWACs; all federal engagement flows through direct purchase orders issued by individual federal agencies. The vendor's federal customer base spans thirty-six distinct agencies, with emphasis on research institutions within the Departments of Health and Human Services, Defense, and Agriculture.
Quick answers
Is Graphpad Software, LLC registered in SAM.gov?
Yes. Graphpad Software, LLC's SAM.gov registration is active through December 16, 2026.
How much has Graphpad Software, LLC received in federal contracts?
Federal contracts obligated $322,295 to Graphpad Software, LLC in fiscal year 2025 and $930,869 in fiscal years 2023 through 2027.
What is Graphpad Software, LLC's most recent federal award?
Graphpad Software, LLC's most recent federal contract award is Nichd graphpad prism (7571TE26P00103), from Assistant Secretary for Financial Resources, on September 1, 2026.
On GovTribe
See Graphpad Software, LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors